HCPLive Network

Most Doctors Believe They Under-Use Mobile Apps

TUESDAY, June 11 (HealthDay News) -- Most physicians feel they are not maximizing use of mobile applications, and would utilize additional electronic health record (EHR) functionalities if they were available, according to poll conducted by Black Book Market Research.

Noting that first EHR vendor results were disappointing and that nearly one in five users indicated high likelihood of switching systems, researchers from Black Book Rankings polled physicians to examine mobile device EHR application demand.

According to the survey, 122 vendors reported that by the end of 2013 they planned to introduce fully-functional mobile access and/or iPad versions of their EHR products. A further 135 vendors reported that mobile applications were on the near horizon. Although most (89 percent) primary care and internal medicine doctors used smartphones to communicate with staff and about half used tablets for independent medical reference and Internet research, less than 1 percent believed that they were maximizing use of applications. Few office-based physicians (8 percent) currently used their mobile devices for electronic prescribing, accessing records, ordering tests, and viewing results; however, most physicians (83 percent) would immediately utilize additional functionalities, including updating patient charts, checking laboratory tests, and ordering medications, if available via their current EHR. The most popular mobile devices currently used were iPhones (68 percent), iPads and tablets (59 percent), and smart/Android phones/other (31 percent).

"The vast majority of all survey respondents favored mobile applications that focus on the patient data and core parts of medical practice most needed when the physician is away from the office setting," Douglas Brown, chief executive officer of Black Book Market Research, said in a statement.

More Information

Copyright © 2013 HealthDay. All rights reserved.

Further Reading
Atherosclerotic internal carotid artery disease is a major contributor to ischemic stroke. Surgeons use a combination of carotid artery and brain imaging to determine if patients have symptomatic carotid stenosis. However, there remains widespread disagreement on the threshold, timing, and best technical approach to carotid revascularization in symptomatic patients.
The FDA has cleared a blood test that can screen patients, especially black women, for coronary heart disease.
The chemical compound indazole chloride (Ind-Cl) initiated long lasting relief in mice models of multiple sclerosis.
More Reading